Press Release Details

Kiniksa Pharmaceuticals to Present at the 2018 Wells Fargo Healthcare Conference


HAMILTON, BERMUDA, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will be presenting at the 2018 Wells Fargo Healthcare Conference on Thursday, September 6th, 2018 at 8:00 a.m. Eastern Time at The Westin Copley Place in Boston, MA.

A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at A replay of the webcast will be available on Kiniksa’s website for 14 days following the conference.

About Kiniksa
Kiniksa is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa has a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune conditions. For more information, please visit

Every Second Counts!™

Kiniksa Investor and Media Contact
Mark Ragosa
(781) 430-8289

Primary Logo

Source: Kiniksa Pharmaceuticals, Ltd.